Salary
Advice & Tips
Calculate Your Salary Ranking
47
 
52
 
50
 
76
Home > Amicus Therapeutics Salary

Amicus Therapeutics Salary

Amicus Therapeutics average salary is $171,847, median salary is $210,000 with a salary range from $90,000 to $215,539.
Amicus Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Amicus Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
90,000
Average
171,847
Median
210,000
High
215,539
Total 3 Amicus Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Other 90,000-90,000 Cranbury, NJ, 08512 2012 Amicus Therapeutics Other Salaries (1)
Amicus Therapeutics Cranbury, NJ Salaries
All Other, Physicians & Surgeons 215,539-215,539 Cranbury, NJ, 08512 2011 Amicus Therapeutics All Other, Physicians & Surgeons Salaries (1)
Amicus Therapeutics Cranbury, NJ Salaries
Clinical Research, Medical Director 210,000-210,000 Cranbury, NJ, 08512 2008 Amicus Therapeutics Clinical Research, Medical Director Salaries (1)
Amicus Therapeutics Cranbury, NJ Salaries
1
Amicus Therapeutics Jobs
See more Amicus The Jobs »
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Amicus Therapeutics Salaries (October 30, 2014)
Other Amicus Therapeutics $90,000 Cranbury, NJ, 08512 09/07/2012

Amicus Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Amicus Therapeutics Information
  • Amicus Therapeutics
  • Industry: BioTech/Drugs
  • City: Cranbury, NJ
  • Amicus was established in April 2002 with seed financing provided by CHL Medical Partners II, a venture capital fund managed by Collinson, Howe & Lenn
  • Amicus Therapeutics Profile
  • Matthew Patterson